Runing Keli (乳宁颗粒)乳宁颗粒

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

柴胡是一种在国家药监局注册认定的药品。该药品含有丹参、当归、柴胡-e8f971d6等成分。

该药品关联的活性成分包括:丹参salvia、当归Dang Gui、柴胡Chai Hu、王不留行Wangbu Liuxing、茯苓Fu Ling。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:南京同仁堂药业有限责任公司Chinese legal name: 南京同仁堂药业有限责任公司。

您可以探索含有相同成分的其他药品:丹参-d5a58f0e成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 乳宁颗粒) is a medicine registered with the national drug regulatory authority. It contains salvia and other recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 丹参salvia, 当归Dang Gui, 柴胡Chai Hu, 王不留行Wangbu Liuxing, 茯苓Fu Ling.

Manufacturers recorded for this product: 南京同仁堂药业有限责任公司Chinese legal name: 南京同仁堂药业有限责任公司.

Explore other medicines containing the same ingredient: 丹参 productssalvia products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 乳宁颗粒Recorded Chinese name: 乳宁颗粒
  • 剂型Dosage form: 颗粒剂Granules
  • 规格Specification: 15g*6袋15 g × 6 sachets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 南京同仁堂药业有限责任公司Chinese legal name: 南京同仁堂药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z10970003

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z10970003

Manufacturer

Chinese legal name: 南京同仁堂药业有限责任公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

15 g × 6 sachets

中文说明书原文Original Chinese source label

批准文号

国药准字Z10970003

生产企业

南京同仁堂药业有限责任公司(国产)

功能主治

疏肝养血,理气解郁。用于两胁胀痛,乳房结节压痛,经前乳房疼痛,月经不调。乳腺增生。

用法用量

开水冲服。一次1袋,一日3次;20天为一个疗程,或遵医嘱。

不良反应

1.经期不准行经延长,经量增多
2.胃部饱胀不适,上腹胀痛,恶心,呕吐,大便溏薄,便次增多,以及口干,乏力,头痛

禁忌

孕妇忌服

注意事项

1.孕妇忌服。
2.如出现不良反应,停药后症状即可得到改善。

贮藏

密封。

规格

15g*6袋

证据Evidence

  • 批准文号: 国药准字Z10970003
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.